About the Scheme
The Regional Open Access Publication Fee Scheme enables NSW Regional Cancer Research Network members to publish Open Access, peer-reviewed cancer research by funding Article Processing Charges. The scheme supports dissemination of regionally informed research that builds capacity, translates evidence into practice, and improves outcomes for people in regional, rural and remote NSW.
Eligibility
- NSW Regional Cancer Research Network member. Join here if you’re not yet a member.
- Authorship: First author (including co‑first where the journal indicates equal contribution) or corresponding author (including co‑corresponding as designated by the journal). Last/senior authors are eligible only if they are the designated corresponding author.
- Alignment with Network aims (refer to scheme guidelines), including a focus on regional, rural or remote communities where applicable. Applications are welcome for:
- Articles arising from NSWRCRN‑funded projects, or
- Articles that clearly align with the Network’s aims.
- Peer‑reviewed & Open Access: Provide evidence the article has been accepted in a peer‑reviewed journal and will be published Open Access.
- Invoice window: Provide a publisher invoice dated between 1 October 2025 and 31 May 2026.
- Acknowledgement: Agree to acknowledge NSWRCRN support in the publication.
- UON authors: For University of Newcastle‑affiliated authors, confirm the journal is not covered by a Library Read & Publish agreement or that the agreement cap has been reached.
For full details and evidence requirements, please refer to the scheme guidelines.
Key Dates
- Applications open: 22 October 2025
- Applications close: Open until funds are expended or by 31 May 2026
- Notification of outcomes: Within 10 business days of submission
Senior Research Partner (SRP) Support
Need help before you apply? If your manuscript is not quite ready, our Senior Research Partners (SRPs) can assist with manuscript preparation, strengthening and review before submission. Accessing SRP support is optional and does not influence funding decisions.